Smith & Nephew to acquire pressure injury monitor maker Leaf
1st Apr 2019 09:33
(Sharecast News) - Medical technology company Smith & Nephew has agreed to acquire Leaf Healthcare - the developer of the Leaf Patient Monitoring System for pressure injury prevention and patient mobility monitoring - it announced on Monday.
Read moreSmith & Nephew to buy US biotech Osiris Therapeutics for $19 a share
12th Mar 2019 13:06
(Sharecast News) - Medical devices maker Smith & Nephew has agreed to buy US biotechnology company Osiris Therapeutics for $19 per share, which is an enterprise value of around $660m.
Read moreSmith & Nephew drops on NuVasive deal report
11th Feb 2019 09:19
(Sharecast News) - Shares in Smith & Nephew fell on Monday following a report that the maker of hip and knee replacement products is in discussions to buy US medical equipment company NuVasive for more than $3bn.
Read moreThursday preview: BoE in focus
6th Feb 2019 12:11
(Sharecast News) - All eyes will be on the Bank of England today and not just on these shores, given how a 'no-deal' Brexit outcome, and its fall-out, might come just as global growth is at its lowest ebb, in early 2019.
Read moreThursday broker round-up
31st Jan 2019 12:42
(Sharecast News) - Ferrexpo: Deutsche Bank upgrades to buy with a target price of 270p.
Read moreSmith and Nephew acquires US orthopaedics outfit
18th Dec 2018 17:10
(Sharecast News) - Medical technology outfit Smith and Nephew has agreed to acquire Ceterix Orthopaedics in a deal valued as much as $105m.
Read moreMonday broker round-up
10th Dec 2018 13:19
(Sharecast News) - RSA: Jefferies upgrades to buy with a target price of 606p.
Read moreFriday broker round-up
2nd Nov 2018 12:26
(Sharecast News) - Moneysupermarket.com: Liberum upgrades to buy with a target price of 500p.
Read moreBerenberg ups target price on 'sensible' Smith and Nephew
2nd Nov 2018 11:57
(Sharecast News) - Analysts at Berenberg increased their target price on medical equipment manufacturer Smith and Nephew on Friday, but noted that the improved earnings growth reported by the FTSE 100 resident in its third-quarter results appeared to already be priced in.
Read moreSmith & Nephew Q3 sales boosted by US, emerging markets
1st Nov 2018 07:23
(Sharecast News) - Smith & Nephew posted a rise in third-quarter revenue on Thursday as it backed its full-year guidance.
Read moreUBS casts doubt on Smith & Nephew's orthopaedic footprint
8th Aug 2018 15:22
(Sharecast News) - A survey of surgeons by UBS has indicated that Smith & Nephew's share of the orthopaedic surgical robots market will not be as big as first thought, leading to analysts downgrading their rating on the shares.
Read moreMonday broker round-up
13th Feb 2017 08:26
(ShareCast News) - Berkeley Group: Barclays reiterates Equal Weight with a target price of 3175p. Flybe Group: HSBC reiterates Buy with a target price of 55p. Esure Group: Berenberg maintains Sell with a target price of 193p. Berendsen: Citigroup reiterates Neutral with a target price of 930p. Sm
Read moreFTSE 100 movers: Rio Tinto zips higher as Reckitt Benckiser falls
10th Feb 2017 17:10
(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser. London's top tier index closed 0.40% higher to 7,258.75 poin
Read moreFriday broker round-up
10th Feb 2017 10:35
(ShareCast News) - British American Tobacco: Berenberg upgrades to Buy with a target price of 5670p. Smith & Nephew: Jefferies reiterates Buy with a target price of 1350p. BT Group: UBS maintains Neutral with a target price of 325p. Ashmore Group: UBS maintains Buy with a target price of 390p. Da
Read moreSmith & Nephew creaks to full year targets thanks to US growth
9th Feb 2017 07:48
(ShareCast News) - Smith & Nephew reported full year sales and earnings in line with consensus forecasts as growth from the US and most emerging markets struggled to offset weakness in China and flat markets elsewhere. With China having returned to growth in the second half of the year and other eme
Read more